Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Increased Heme Oxygenase 1 Expression upon a Primary Exposure to the Respiratory Syncytial Virus and a Secondary <i>Mycobacterium bovis</i> Infection
Indexado
WoS WOS:000846221900001
Scopus SCOPUS_ID:85137322145
DOI 10.3390/ANTIOX11081453
Año 2022
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



The human respiratory syncytial virus (hRSV) is the leading cause of severe lower respiratory tract infections in infants. Because recurrent epidemics based on reinfection occur in children and adults, hRSV has gained interest as a potential primary pathogen favoring secondary opportunistic infections. Several infection models have shown different mechanisms by which hRSV promotes immunopathology to prevent the development of adaptive protective immunity. However, little is known about the long-lasting effects of viral infection on pulmonary immune surveillance mechanisms. As a first approach, here we evaluated whether a primary infection by hRSV, once resolved, dampens the host immune response to a secondary infection with an attenuated strain of Mycobacterium bovis (M. Bovis) strain referred as to Bacillus Calmette-Guerin (BCG). We analyzed leukocyte dynamics and immunomodulatory molecules in the lungs after eleven- and twenty-one-days post-infection with Mycobacterium, using previous hRSV infected mice, by flow cytometry and the expression of critical genes involved in the immune response by real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR). Among the latter, we analyzed the expression of Heme Oxygenase (HO)-1 in an immunization scheme in mice. Our data suggest that a pre-infection with hRSV has a conditioning effect promoting lung pathology during a subsequent mycobacterial challenge, characterized by increased infiltration of innate immune cells, including interstitial and alveolar macrophages. Our data also suggest that hRSV impairs pulmonary immune responses, promoting secondary mycobacterial colonization and lung survival, which could be associated with an increase in the expression of HO-1. Additionally, BCG is a commonly used vaccine that can be used as a platform for the generation of new recombinant vaccines, such as a recombinant BCG strain expressing the nucleoprotein of hRSV (rBCG-N-hRSV). Therefore, we evaluated if the immunization with rBCG-N-hRSV could modulate the expression of HO-1. We found a differential expression pattern for HO-1, where a higher induction of HO-1 was detected on epithelial cells compared to dendritic cells during late infection times. This is the first study to demonstrate that infection with hRSV produces damage in the lung epithelium, promoting subsequent mycobacterial colonization, characterized by an increase in the neutrophils and alveolar macrophages recruitment. Moreover, we determined that immunization with rBCG-N-hRSV modulates differentially the expression of HO-1 on immune and epithelial cells, which could be involved in the repair of pulmonary tissue.

Revista



Revista ISSN
Antioxidants 2076-3921

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Biochemistry & Molecular Biology
Food Science & Technology
Chemistry, Medicinal
Scopus
Molecular Biology
Food Science
Biochemistry
Clinical Biochemistry
Cell Biology
Physiology
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Canedo-Marroquin, Gisela Mujer Pontificia Universidad Católica de Chile - Chile
Universidad de Los Andes, Chile - Chile
2 SOTO-ALVARADO, JOSE ANTONIO Hombre Pontificia Universidad Católica de Chile - Chile
Universidad Nacional Andrés Bello - Chile
3 Andrade-Parra, Catalina Mujer Pontificia Universidad Católica de Chile - Chile
4 BUENO-RAMIREZ, SUSAN MARCELA Mujer Pontificia Universidad Católica de Chile - Chile
5 KALERGIS-PARRA, ALEXIS MIKES Hombre Pontificia Universidad Católica de Chile - Chile
Facultad de Medicina - Chile

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Fondo Nacional de Desarrollo Científico y Tecnológico
Comisión Nacional de Investigación Científica y Tecnológica
Fondo de Fomento al Desarrollo Científico y Tecnológico
Agencia Nacional de Investigación y Desarrollo

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
This work was supported by FONDECYT 1070352; 1190830, FONDEF D061008, FONDEF D11I1080, PAI ANID No. SA77210076, PAI ANID No. SA77210051, ANID/CONICYT scholarship 21210662, and the Millennium Institute on Immunology and Immunotherapy CN09_016/ICN 2021_045; former P09/016-F.
We thank our veterinarian Maria Jose Altamirano for her support in handling and caring for the experimental animals and evaluating the histopathological score. We also thank Francisco Salazar for technical assistance. We also thank Pablo Cespedes (CONICYT/FONDECYT POSTDOCTORADO No. 3140455) for technical assistance and experimental design. Finally, we thank Biorender for partial material used for the design of some figures.

Muestra la fuente de financiamiento declarada en la publicación.